$SRNE finance.yahoo.com/news/mode... $MRNA what a scumbag! Trying to use Govt funding to make up for 10 years of loses Pre COVID “We have to make a profit out of the first product [we sell],” Bancel told Yahoo Finance. “We have invested $2 billion of our shareholder capital since we started the company. We need to get a return. We are highly aware this is a pandemic and we need to be very responsible on how we price a product.” In a separate issue, questions have been raised over the company’s executives selling stock after positive results from early trials. That pattern that has been seen in other newly-popular biotechs.
  • 11
@BROWNEBULL - $MRNA hasn't had a successful product in 10 years and now they're going to jack the vaccine price up.....insiders can't stop dumping.....‘We have to make a profit’ If successful, a vaccine will actually be the 10-year-old company’s first product on the market. Despite significant taxpayer funding, as well as investors boosting its market capitalization to $29 billion, the biotech upstart will need to make a profit — and will consider that in its pricing, Bancel said. Exactly how much a vaccine shot will cost, and who’ll ultimately cover it, remains a big sticking point in the process. “We have to make a profit out of the first product [we sell],” Bancel told Yahoo Finance. “We have invested $2 billion of our shareholder capital since we started the company. We need to get a return. We are highly aware this is a pandemic and we need to be very responsible on how we price a product.”